Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells

Biochemical and Biophysical Research Communications

Volumn 373, Issue 4, 2008, Pages 618-623

  Mak, Paul ^a   Jaggi, Meena ^b   Syed, Viqar ^c   Chauhan, Subhash C ^b   Hassan, Sazzad ^a   Biswas, Helal ^a   Balaji, K C ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b SANFORD RESEARCH   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Androgen receptor; Interaction; Prostate cancer; Protein kinase D1

Indexed keywords

ANDROGEN RECEPTOR; LIGAND; PROSTATE SPECIFIC ANTIGEN; PROTEIN KINASE D; PROTEIN KINASE D1;

ADVANCED CANCER; ARTICLE; CANCER CELL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PSA GENE; RECEPTOR DOWN REGULATION; TRANSCRIPTION INITIATION;

CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN KINASE C; RECEPTORS, ANDROGEN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 48949115076     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.097     Document Type: Article

References (16)

1. Valverde A.M., Sinnett-Smith J., Van Lint J., and Rozengurt E. Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc. Natl. Acad. Sci. USA 91 (1994) 8572-8576
2. Wang Q.J. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol. Sci. 27 (2006) 317-323
3. Jaggi M., Du C., Zhang W., and Balaji K.C. Protein kinase D1: a protein of emerging translational interest. Front. Biosci. 12 (2007) 3757-3767
4. Jaggi M., Roa P.S., Smith D.J., Hemstreet G.P., and Balaji K.C. Protein kinase C mu is down-regulated in androgen independent prostate cancer. Biochem. Biophys. Res. Commun. 307 (2003) 254-260
5. Jaggi M., Rao P.S., Smith D.J., Wheelock M.J., Johnson K.R., Hemstreet G.P., and Balaji K.C. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. Cancer Res. 65 (2005) 483-492
6. Syed V., Mak P., Du C., and Balaji K.C. β-Catenin mediates alterations in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and Protein Kinase D1. J Cell. Biochem. 104 (2008) 82-95
7. Ristich V.L., Bowman P.H., Dodd M.E., and Bollag W.B. Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br. J. Dermatol. 154 (2006) 586-593
8. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
9. Gelmann E.P. Molecular biology of the androgen receptor. J. Clin. Oncol. 20 (2002) 3001-3015
10. Agoulnik I.U., Vaid A., Bingman III W.E., Erdeme H., Frolov A., Smith C.L., Ayala G., Ittmann M.M., and Weigel N.L. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res. 65 (2005) 7959-7967
11. Chmelar R., Buchanan G., Need E.F., Tiley W., and Greenberg N.M. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int. J. Cancer 120 (2006) 719-733
12. Mak P., Young C.Y.-F., and Tindall D.J. A novel yeast expression system to study androgen action. Recent Prog. Horm. Res. 49 (1994) 47-352
13. Salerno A.J., He Z., Goos-Nilsson A., Ahola H., and Mak P. Differential transcriptional activation of the apoAI gene by retinoic acid receptor homo and heterodimers in yeast. Nucleic Acids Res. 24 (1996) 566-572
14. Du C., Ge B., Liu Z., Fu K., Chan W.C., and McKeithan T.W. PCR-based generation of shRNA libraries from cDNA. BMC Biotechnol. 6 (2006) 28
15. Mak P., Leung Y.K., Tang W.Y., Harwood C., and Ho S.M. Apigenin suppresses cancer cell growth through ERβ. Neoplasia 8 (2006) 896-904
16. Xu Y., Chen S.Y., Ross K.N., and Balk S.P. Androgens induce prostate cancer cell proliferation through mammalian target of Rapamycin activation and posttranscriptional increase in cyclin D proteins. Cancer Res. 66 (2006) 7783-7792